NFKB1 and prostate carcinoma: Despite its essential role in maximal NF-κB activation [22], HECTD2 has not been previously associated with the cell cycle and the only currently available data suggest an anti-proliferative role for HECTD2 in androgen-independent growth of the LNCaP prostate cancer cell line [23].